1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Global Asthma Therapeutics Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share &
Forecast
4.2.1.
By Drug Class
(Anti-inflammatory, Combination Therapy, Bronchodilators)
4.2.2.
By Product (Inhalers (Dry powder inhalers, Metered dose
inhalers, Soft mist inhalers), Nebulizers)
4.2.3.
By Route of Administration
(Oral, Inhaled, Others)
4.2.4. By
Region
4.2.5. By Company (2023)
4.3. Market Map
4.3.1. By Drug Class
4.3.2. By Product
4.3.3. By Route of
Administration
4.3.4. By Region
5.
Asia Pacific Asthma Therapeutics Market Outlook
5.1. Market Size &
Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By
Drug Class
5.2.2. By
Product
5.2.3. By
Route of Administration
5.2.4. By Country
5.3. Asia Pacific:
Country Analysis
5.3.1. China Asthma
Therapeutics Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Drug Class
5.3.1.2.2.
By Product
5.3.1.2.3.
By Route of Administration
5.3.2. India Asthma Therapeutics
Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Drug Class
5.3.2.2.2.
By Product
5.3.2.2.3.
By Route of Administration
5.3.3. Australia Asthma
Therapeutics Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Drug Class
5.3.3.2.2.
By Product
5.3.3.2.3.
By Route of Administration
5.3.4. Japan Asthma
Therapeutics Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Drug Class
5.3.4.2.2.
By Product
5.3.4.2.3.
By Route of Administration
5.3.5. South Korea Asthma
Therapeutics Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Drug Class
5.3.5.2.2.
By Product
5.3.5.2.3.
By Route of Administration
6.
Europe Asthma Therapeutics Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1.
By Drug Class
6.2.2.
By Product
6.2.3.
By Route of Administration
6.2.4.
By Country
6.3. Europe: Country
Analysis
6.3.1. France Asthma
Therapeutics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Class
6.3.1.2.2.
By Product
6.3.1.2.3.
By Route of Administration
6.3.2. Germany Asthma
Therapeutics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Class
6.3.2.2.2.
By Product
6.3.2.2.3.
By Route of Administration
6.3.3. Spain Asthma
Therapeutics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Class
6.3.3.2.2.
By Product
6.3.3.2.3.
By Route of Administration
6.3.4. Italy Asthma
Therapeutics Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug Class
6.3.4.2.2.
By Product
6.3.4.2.3.
By Route of Administration
6.3.5. United Kingdom
Asthma Therapeutics Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug Class
6.3.5.2.2.
By Product
6.3.5.2.3.
By Route of Administration
7.
North America Asthma Therapeutics Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1.
By Drug Class
7.2.2.
By Product
7.2.3.
By Route of Administration
7.2.4. By Country
7.3. North America:
Country Analysis
7.3.1. United States Asthma
Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Product
7.3.1.2.3.
By Route of Administration
7.3.2. Mexico Asthma
Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Product
7.3.2.2.3.
By Route of Administration
7.3.3. Canada Asthma
Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Product
7.3.3.2.3.
By Route of Administration
8.
South America Asthma Therapeutics Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1.
By Drug Class
8.2.2.
By Product
8.2.3.
By Route of Administration
8.2.4. By Country
8.3. South America:
Country Analysis
8.3.1. Brazil Asthma Therapeutics
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Product
8.3.1.2.3.
By Route of Administration
8.3.2. Argentina Asthma
Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Product
8.3.2.2.3.
By Route of Administration
8.3.3. Colombia Asthma
Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Product
8.3.3.2.3.
By Route of Administration
9.
Middle East and Africa Asthma Therapeutics Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1.
By Drug Class
9.2.2.
By Product
9.2.3.
By Route of Administration
9.2.4. By Country
9.3. MEA: Country
Analysis
9.3.1. South Africa Asthma
Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Product
9.3.1.2.3.
By Route of Administration
9.3.2. Saudi Arabia Asthma
Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Product
9.3.2.2.3.
By Route of Administration
9.3.3. UAE Asthma
Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Product
9.3.3.2.3.
By Route of Administration
10. Market Dynamics
10.1.
Drivers
10.2.
Challenges
11. Market Trends &
Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers & Acquisitions
12. Global Asthma
Therapeutics Market: SWOT Analysis
13.
Porter’s Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Product
14. Competitive
Landscape
14.1.
Teva
Pharmaceutical Industries Ltd.
14.1.1. Business Overview
14.1.2.
Company Snapshot
14.1.3.
Product & Services
14.1.4. Financials (In case of listed)
14.1.5.
Recent Developments
14.1.6.
SWOT Analysis
14.2. GSK plc.
14.3. Merck & Co., Inc.
14.4. F. Hoffmann-La Roche
Ltd.
14.5. AstraZeneca plc.
14.6. Boehringer Ingelheim
International GmbH
14.7. Sanofi S.A.
14.8. Koninklijke Philips
N.V.
14.9. Becton, Dickinson
and Company
14.10. Sunovion
Pharmaceuticals, Inc.
15. Strategic Recommendations
16. About
Us & Disclaimer